Cargando…

Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software

INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendousl...

Descripción completa

Detalles Bibliográficos
Autores principales: Akter, Sanjida, Hassan, Md. Rajib, Shahriar, Mohammad, Akter, Nahia, Abbas, Md. Golam, Bhuiyan, Mohiuddin Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696341/
https://www.ncbi.nlm.nih.gov/pubmed/26714488
http://dx.doi.org/10.1186/s13195-015-0164-8
_version_ 1782407781247090688
author Akter, Sanjida
Hassan, Md. Rajib
Shahriar, Mohammad
Akter, Nahia
Abbas, Md. Golam
Bhuiyan, Mohiuddin Ahmed
author_facet Akter, Sanjida
Hassan, Md. Rajib
Shahriar, Mohammad
Akter, Nahia
Abbas, Md. Golam
Bhuiyan, Mohiuddin Ahmed
author_sort Akter, Sanjida
collection PubMed
description INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendously for the last few years, it is of great public health importance to investigate the cognitive impact of PPIs. Hence, the purpose of this study was to investigate the degree of neuropsychological association of each PPI with different cognitive functions. METHODS: Sixty volunteers of either gender were recruited and divided randomly into six groups: five test groups for five classes of PPIs and one control group. All the groups participated in the five computerized neuropsychological tests (nine subtests) of the Cambridge Neuropsychological Test Automated Battery twice: at the beginning of the study and 7 days thereafter. RESULTS: We found statistically and clinically significant impairment in visual memory, attention, executive function, and working and planning function. One-way analysis of variance findings showed that all PPIs had a similar negative impact on cognition. However, paired-samples t tests indicated that omeprazole showed significant (p < 0.05) results in seven subtests; lansoprazole and pantoprazole showed significant results in five subtests; and rabeprazole showed significant results in four subtests. Among five classes of PPIs, esomeprazole showed comparatively less impact on cognitive function with significant results in three subtests. CONCLUSIONS: The present study reveals for the first time that different PPIs have varying degrees of influence on different cognitive domains and have associations with AD. These findings should be considered when balancing the risks and benefits of prescribing these medications. A study done for a longer period of time with a larger sample size might yield better results.
format Online
Article
Text
id pubmed-4696341
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46963412015-12-31 Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software Akter, Sanjida Hassan, Md. Rajib Shahriar, Mohammad Akter, Nahia Abbas, Md. Golam Bhuiyan, Mohiuddin Ahmed Alzheimers Res Ther Research INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendously for the last few years, it is of great public health importance to investigate the cognitive impact of PPIs. Hence, the purpose of this study was to investigate the degree of neuropsychological association of each PPI with different cognitive functions. METHODS: Sixty volunteers of either gender were recruited and divided randomly into six groups: five test groups for five classes of PPIs and one control group. All the groups participated in the five computerized neuropsychological tests (nine subtests) of the Cambridge Neuropsychological Test Automated Battery twice: at the beginning of the study and 7 days thereafter. RESULTS: We found statistically and clinically significant impairment in visual memory, attention, executive function, and working and planning function. One-way analysis of variance findings showed that all PPIs had a similar negative impact on cognition. However, paired-samples t tests indicated that omeprazole showed significant (p < 0.05) results in seven subtests; lansoprazole and pantoprazole showed significant results in five subtests; and rabeprazole showed significant results in four subtests. Among five classes of PPIs, esomeprazole showed comparatively less impact on cognitive function with significant results in three subtests. CONCLUSIONS: The present study reveals for the first time that different PPIs have varying degrees of influence on different cognitive domains and have associations with AD. These findings should be considered when balancing the risks and benefits of prescribing these medications. A study done for a longer period of time with a larger sample size might yield better results. BioMed Central 2015-12-27 /pmc/articles/PMC4696341/ /pubmed/26714488 http://dx.doi.org/10.1186/s13195-015-0164-8 Text en © Akter et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Akter, Sanjida
Hassan, Md. Rajib
Shahriar, Mohammad
Akter, Nahia
Abbas, Md. Golam
Bhuiyan, Mohiuddin Ahmed
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title_full Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title_fullStr Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title_full_unstemmed Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title_short Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
title_sort cognitive impact after short-term exposure to different proton pump inhibitors: assessment using cantab software
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696341/
https://www.ncbi.nlm.nih.gov/pubmed/26714488
http://dx.doi.org/10.1186/s13195-015-0164-8
work_keys_str_mv AT aktersanjida cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware
AT hassanmdrajib cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware
AT shahriarmohammad cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware
AT akternahia cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware
AT abbasmdgolam cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware
AT bhuiyanmohiuddinahmed cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware